Search for dissertations about: "duration of disease onset"
Showing result 1 - 5 of 87 swedish dissertations containing the words duration of disease onset.
-
1. Biomarkers for diagnosis and prognosis in amyotrophic lateral sclerosis
Abstract : Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by loss of upper and lower motor neurons, leading to paresis, muscle atrophy, and respiratory failure. ALS can be difficult to diagnose and prognosticate early. READ MORE
-
2. Parkinson’s disease : the prodromal phase and consequences with respect to working life
Abstract : Background: Parkinson’s disease (PD) is a common, progressive neurodegenerative disorder, recognized by the motor symptoms of bradykinesia, tremor, rigidity, and postural impairment. At clinical onset, extensive amounts of dopaminergic neurons have already been lost. READ MORE
-
3. Consequences of brain tumours from the perspective of the patients and of their next of kin
Abstract : A disease has consequences not only for the afflicted person but also for those who interact with him or her. A low-grade glioma is a brain tumour whose regarding its psychosocial implications for adult patients and their next of kin has received little attention in the literature. READ MORE
-
4. Psychopathology in Wilson's Disease
Abstract : Wilson's disease (WD), bepatolenticular degeneration, is an autosomal recessive disorder caused by mutations in the ATP7B gene, and is characterised by abnormal metabolism and deposition of copper in the liver, brain and other organs. The main aim of this thesis was to investigate the occurrence of psychopathology, as well as personality traits and neuropsychological function in Swedish patients with treated WD. READ MORE
-
5. Factors influencing the risk of diabetic nephropathy : analyses of genes, smoking and diet
Abstract : Diabetic long-term complications, despite intensive treatment, cause serious handicaps at relatively young age in diabetic patients. Diabetic nephropathy (DN) develops in up to 30% of patients with type 1 diabetes (T1D). READ MORE